HIV-1 CONSENSUS B VIF-29 serves as a consensus-derived peptide fragment for analyzing Vif-relevant structural dynamics. Its sequence assists in mapping conserved interaction sites and stability boundaries. Researchers utilize it for motif comparison and interface probing. The peptide contributes to biophysical assessments of protein assembly behavior.
CAT No: H09222
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.